These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20496170)

  • 21. Colorectal cancer screening with faecal occult blood testing: community intention, knowledge, beliefs and behaviour.
    Tong S; Hughes K; Oldenburg BB; Mar CD
    Asia Pac J Public Health; 2006; 18(1):16-23. PubMed ID: 16629434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner.
    Cole SR; Young GP; Byrne D; Guy JR; Morcom J
    J Med Screen; 2002; 9(4):147-52. PubMed ID: 12518003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Access to Health Care, Beliefs, and Behaviors about Colorectal Cancer Screening among Korean Americans.
    Lee SY; Lee EE
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):2021-2027. PubMed ID: 30051703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community.
    Hughes K; Leggett B; Del Mar C; Croese J; Fairley S; Masson J; Aitken J; Clavarino A; Janda M; Stanton WR; Tong S; Newman B
    Aust N Z J Public Health; 2005 Aug; 29(4):358-64. PubMed ID: 16222934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Likelihood of a fecal occult blood test uptake among older adults: comparisons between health professionals and healthcare volunteers based on the health belief model.
    Lin TY; Chuang ST; Huang SF; Hsu HP; Lu LT; Guo JL
    BMC Geriatr; 2019 Feb; 19(1):51. PubMed ID: 30791892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer.
    Cole SR; Young GP
    Med J Aust; 2001 Aug; 175(4):195-8. PubMed ID: 11587278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticipated regret to increase uptake of colorectal cancer screening (ARTICS): A randomised controlled trial.
    O'Carroll RE; Chambers JA; Brownlee L; Libby G; Steele RJ
    Soc Sci Med; 2015 Oct; 142():118-27. PubMed ID: 26301484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychological distress after a positive fecal occult blood test result among members of an integrated healthcare delivery system.
    Laing SS; Bogart A; Chubak J; Fuller S; Green BB
    Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):154-9. PubMed ID: 24220914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update.
    Hewitson P; Glasziou P; Watson E; Towler B; Irwig L
    Am J Gastroenterol; 2008 Jun; 103(6):1541-9. PubMed ID: 18479499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in behavioral outcomes between first-year and second-year participants in a community-based colorectal cancer education intervention.
    Huang JY; Shi L
    Asian Pac J Cancer Prev; 2011; 12(12):3323-9. PubMed ID: 22471474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attitudes towards and beliefs about colorectal cancer and screening using the faecal occult blood test within the Italian-Australian community.
    Severino G; Wilson C; Turnbull D; Duncan A; Gregory T
    Asian Pac J Cancer Prev; 2009; 10(3):387-94. PubMed ID: 19640179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-perceived Mental Health Status and Uptake of Fecal Occult Blood Test for Colorectal Cancer Screening in Canada: A Cross-Sectional Study.
    Hategekimana C; Karamouzian M
    Int J Health Policy Manag; 2016 Feb; 5(6):365-71. PubMed ID: 27285514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors of Never Screened with Faecal Occult Blood Test in Public Primary Care Facilities.
    Sazali MF; Syed Abdul Rahim SS; Avoi R; Hassan MR; Hayati F; Azhar ZI; Jeffree MS; Awang Lukman K; Oo Tha N; Sajali H; Atil A; Abd Rahim MA
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):163-169. PubMed ID: 33507695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lifestyle changes associated with participation in colorectal cancer screening: Prospective data from the English Longitudinal Study of Ageing.
    Stevens C; Smith SG; Vrinten C; Waller J; Beeken RJ
    J Med Screen; 2019 Jun; 26(2):84-91. PubMed ID: 30336731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attitudes, knowledge and practice of CRC screening among GPs in Queensland.
    Youl PH; Jackson C; Oldenburg B; Brown C; Dunn J; Aitken J
    Aust Fam Physician; 2006 Jul; 35(7):547-50. PubMed ID: 16820832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
    Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors Associated With Colonoscopy Compliance Based on Health Belief Model in a Community-Based Colorectal Cancer Screening Program Shanghai, China.
    He L; Gao S; Tao S; Li W; Du J; Ji Y; Wang Y
    Int Q Community Health Educ; 2020 Oct; 41(1):25-33. PubMed ID: 31876256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding of a negative bowel screening result and potential impact on future symptom appraisal and help-seeking behaviour: a focus group study.
    Barnett KN; Weller D; Smith S; Orbell S; Vedsted P; Steele RJC; Melia JW; Moss SM; Patnick J; Campbell C
    Health Expect; 2017 Aug; 20(4):584-592. PubMed ID: 27414462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population characteristics related to colorectal cancer testing in New South Wales, Australia: results from the 45 and Up Study cohort.
    Weber MF; Banks E; Ward R; Sitas F
    J Med Screen; 2008; 15(3):137-42. PubMed ID: 18927096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of the OC Sensor
    Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX
    Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.